Already a Subscriber?

Not a Subscriber?

Executive Interview: "Finding Success in China: The Biosensors Story"

By David Cassak, Co-Editor-in-Chief

Two decades ago, Singapore-based Biosensors International developed an innovative drug-eluting stent with a bio-degradable polymer. But rather than focusing on the US market, the company built an enormously successful business by targeting China – and other Asian markets – well before any other company had identified China as an important market. In this interview, Biosensors founder and former CEO Yoh-Chie Lu talks about Biosensors’ success and the evolution of the Chinese market.

Reproductive Medicine - "How Genomics, Big Data, and Consumerism are Bringing Entrepreneurial Opportunities to Infertility"

By Wendy Diller, Senior Writer/Market Analyst

The field of fertility treatment is ripe for technological and business model innovation, based on technology advances and computational analysis that improves the workflow of clinics and provides the information that patients need to make better choices.

Digital Health - "Virtual Reality Enters Physician Training: A Conversation with Sandra Humbles and David Badri of the Johnson & Johnson Institute"

By Mary Thompson, Executive Editor

Virtual reality and other tech-enabled digital tools are entering the healthcare education arena with a promise to make clinician training and assessment more flexible, efficient, and user-friendly. One of the most active pioneers in this space is medtech giant Johnson & Johnson. J&J’s professional education unit, the Johnson & Johnson Institute, is embracing a variety of digital learning tools, ranging from virtual and augmented reality to AI-driven online learning tools. And its efforts could have far-reaching implications for both J&J and the clinicians it serves. 

Outside Opinion - "Beware the Seductions of M&A"

By Mark Speers, Health Advances

A leading medtech consultant points out some of the potential missteps that device executives may not consider when caught up in the excitement of the M&A path.

Start-Ups To Watch - ENT/Otolaryngology: "Neurent Medical: An Office-Based Procedure Treats Rhinitis"

By Mary Stuart, Senior Writer/Market Analyst

Now that companies developing treatments for sinusitis have created a demand for office-based ENT procedures, Neurent Medical hopes to fill the need with a minimally-invasive intervention for the 40-60 million people in the US who suffer from rhinitis.

Start-Ups To Watch - Infertility: "Univfy: Personalized Prognostics for Successful, Accessible IVF Treatment"

By Wendy Diller, Senior Writer/Market Analyst

Due to cost, stigma, and unpredictable outcomes, access to successful IVF treatment is limited to a small percentage of the more than seven million women in the US who suffer from infertility. Univfy’s rigorously developed, customized prognostics relieve barriers by improving the odds of live births and offering better financial options for patients.

Not a Subscriber?

Already a Subscriber?

Want a Sample Article?